Beauchamp LC, Ellett LJ, Juan SMA, Liu XM, Hunt CPJ, Parish CL, Jacobson LH, Shepherd CE, Halliday GM, Bush AI, Vella LJ, Finkelstein DI, Barnham KJ (2025) Evidence of COMT dysfunction in the olfactory bulb in parkinson’s disease. Acta Neuropathol 149:21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camargo CHF, Jobbins VA, Serpa RA, Berbetz FA, Sabatini JS, Teive HAG (2018) Association between olfactory loss and cognitive deficits in parkinson’s disease. Clin Neurol Neurosurg 173:120–123

Article  PubMed  Google Scholar 

Cecchini MP, Mantovani E, Federico A, Zanini A, Ottaviani S, Masala C, Tinazzi M, Tamburin S (2021) Olfaction in patients with parkinson’s disease: a new threshold test analysis through turning points trajectories. J Neural Transm (Vienna) 128:1641–1653

Article  PubMed  Google Scholar 

Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, Macphee G, Kelly L, Rabey M, Macmahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923

Article  PubMed  Google Scholar 

Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH (2007) The metric properties of a novel non-motor symptoms scale for parkinson’s disease: results from an international pilot study. Mov Disord 22:1901–1911

Article  PubMed  Google Scholar 

Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol 16:478–488

Article  PubMed  Google Scholar 

Fahn S, Elton R, Members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. 153–163 New York, Macmillan

Fatuzzo I, Niccolini GF, Zoccali F, Cavalcanti L, Bellizzi MG, Riccardi G, de Fiore VM, Petrella M, Minni C, Barbato A C (2023) Neurons, nose, and neurodegenerative diseases: olfactory function and cognitive impairment. Int J Mol Sci 24:2117

Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss May be a first sign of idiopathic parkinson’s disease. Mov Disord 22:839–842

Article  PubMed  Google Scholar 

Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic parkinson’s disease. J Neurol 255:367–370

Article  PubMed  Google Scholar 

Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

Article  CAS  PubMed  Google Scholar 

Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110:976–981

Article  CAS  PubMed  Google Scholar 

Kawabata K, Bagarinao E, Seppi K, Poewe W (2024) Longitudinal brain changes in parkinson’s disease with severe olfactory deficit. Parkinsonism Relat Disord 122:106072

Article  PubMed  Google Scholar 

Leonhardt B, Tahmasebi R, Jagsch R, Pirker W, Lehrner J (2019) Awareness of olfactory dysfunction in parkinson’s disease. Neuropsychology 33:633–641

Article  PubMed  Google Scholar 

Löhle M, Wolz M, Beuthien-Baumann B, Oehme L, van den Kotzerke HJ, Reichmann J, Storch H A (2020) Olfactory dysfunction correlates with putaminal dopamine turnover in early de Novo parkinson’s disease. J Neural Transm (Vienna) 127:9–16

Article  PubMed  Google Scholar 

Müller T (2014) Tolcapone addition improves parkinson’s disease associated nonmotor symptoms. Ther Adv Neurol Disord 7:77–82

Article  PubMed  PubMed Central  Google Scholar 

Müller T (2022) What are the main considerations when prescribing pharmacotherapy for parkinson’s disease? Expert Opin Pharmacother 23:745–750

Article  PubMed  Google Scholar 

Müller T, Öhm G, Eilert K, Möhr K, Rotter S, Haas T, Küchler M, Lütge S, Marg M, Rothe H (2017) Benefit on motor and non-motor behavior in a specialized unit for parkinson’s disease. J Neural Transm (Vienna) 124:715–720

Article  PubMed  Google Scholar 

Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML (2012) Olfactory deficits and cognitive dysfunction in parkinson’s disease. Neurodegener Dis 10:179–182

Article  PubMed  Google Scholar 

Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, Müller T, Jost W, Ebersbach G, Gold R, Krogias C, Tönges L (2019) Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010(-)2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers. Cells 8:151

Roos DS, Klein M, Doty RL, Berendse HW (2024) Decline of olfactory function in parkinson’s disease: A ten-year longitudinal study. J Parkinsons Dis 14:1877718X241298708

Article  PubMed  Google Scholar 

Rossi M, Perez-Lloret S, Millar VP, Drucaroff L, Costanzo E, Ballesteros D, Bril A, Cerquetti D, Guinjoan S, Merello M (2015) Olfactory dysfunction evaluation is not affected by comorbid depression in parkinson’s disease. Mov Disord 30:1275–1279

Article  PubMed  Google Scholar 

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H, Kumar H, Banerjee R, Erro R, Bhidayasiri R, Schrag A, Zis P, Lim SY, Al-Hashel JY, Kamel WA, Martinez-Martin P, Ray CK (2017) Non-Motor symptoms assessed by Non-Motor symptoms questionnaire and Non-Motor symptoms scale in parkinson’s disease in selected Asian populations. Neuroepidemiology 49:1–17

Article  PubMed  Google Scholar 

Scherbaum R, Hollerhage M, Klebe S, Riederer P, Müller T, Schroter N, Weise D, Woitalla D, Tönges L (2025) Parkinson’s Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson’s disease in Germany and the needs of future development. J Neural Transm (Vienna). https://doi.org/10.1007/s00702-025-02963-7

Titova N, Chaudhuri KR (2017) Personalized medicine in parkinson’s disease: time to be precise. Mov Disord 32:1147–1154

Article  PubMed  PubMed Central  Google Scholar 

Ubeda-Banon I, Saiz-Sanchez D, De lR-P, Martinez-Marcos A (2014) alpha-Synuclein in the olfactory system in parkinson’s disease: role of neural connections on spreading pathology. Brain Struct Funct 219:1513–1526

CAS  PubMed  Google Scholar